These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31029587)

  • 1. Null mutation in P4h-tm leads to decreased fear and anxiety and increased social behavior in mice.
    Leinonen H; Koivisto H; Lipponen HR; Matilainen A; Salo AM; Dimova EY; Hämäläinen E; Stavén S; Miettinen P; Myllyharju J; Koivunen P; Tanila H
    Neuropharmacology; 2019 Jul; 153():63-72. PubMed ID: 31029587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of P4H-TM in mice results in age-related retinal and renal alterations.
    Leinonen H; Rossi M; Salo AM; Tiainen P; Hyvärinen J; Pitkänen M; Sormunen R; Miinalainen I; Zhang C; Soininen R; Kivirikko KI; Koskelainen A; Tanila H; Myllyharju J; Koivunen P
    Hum Mol Genet; 2016 Sep; 25(17):3810-3823. PubMed ID: 27466183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and Roles of Individual HIF Prolyl 4-Hydroxylase Isoenzymes in the Regulation of the Hypoxia Response Pathway along the Murine Gastrointestinal Epithelium.
    Dengler F; Sova S; Salo AM; Mäki JM; Koivunen P; Myllyharju J
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmembrane prolyl 4-hydroxylase is a fourth prolyl 4-hydroxylase regulating EPO production and erythropoiesis.
    Laitala A; Aro E; Walkinshaw G; Mäki JM; Rossi M; Heikkilä M; Savolainen ER; Arend M; Kivirikko KI; Koivunen P; Myllyharju J
    Blood; 2012 Oct; 120(16):3336-44. PubMed ID: 22955912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.
    Rahtu-Korpela L; Määttä J; Dimova EY; Hörkkö S; Gylling H; Walkinshaw G; Hakkola J; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):608-17. PubMed ID: 26848160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of mouse transmembrane prolyl 4-hydroxylase increases blood brain barrier permeability and ischemia-induced cerebral neuroinflammation.
    Byts N; Sharma S; Malm T; Kaakinen M; Korhonen P; Jaakkonen L; Keuters M; Huuskonen M; Pietilä I; Koistinaho J; Koivunen P; Myllyharju J
    J Biol Chem; 2022 Mar; 298(3):101721. PubMed ID: 35151685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An endoplasmic reticulum transmembrane prolyl 4-hydroxylase is induced by hypoxia and acts on hypoxia-inducible factor alpha.
    Koivunen P; Tiainen P; Hyvärinen J; Williams KE; Sormunen R; Klaus SJ; Kivirikko KI; Myllyharju J
    J Biol Chem; 2007 Oct; 282(42):30544-52. PubMed ID: 17726031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-Inducible Factor Prolyl 4-Hydroxylases and Metabolism.
    Koivunen P; Kietzmann T
    Trends Mol Med; 2018 Dec; 24(12):1021-1035. PubMed ID: 30391126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIF-P4H-2 deficiency protects against skeletal muscle ischemia-reperfusion injury.
    Karsikas S; Myllymäki M; Heikkilä M; Sormunen R; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
    J Mol Med (Berl); 2016 Mar; 94(3):301-10. PubMed ID: 26452676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic inactivation of hypoxia-inducible factor prolyl 4-hydroxylase 2 in mice protects from alcohol-induced fatty liver disease.
    Laitakari A; Ollonen T; Kietzmann T; Walkinshaw G; Mennerich D; Izzi V; Haapasaari KM; Myllyharju J; Serpi R; Dimova EY; Koivunen P
    Redox Biol; 2019 Apr; 22():101145. PubMed ID: 30802717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of hypoxia response in endothelial cells contributes to ischemic cardioprotection.
    Kerkelä R; Karsikas S; Szabo Z; Serpi R; Magga J; Gao E; Alitalo K; Anisimov A; Sormunen R; Pietilä I; Vainio L; Koch WJ; Kivirikko KI; Myllyharju J; Koivunen P
    Mol Cell Biol; 2013 Aug; 33(16):3321-9. PubMed ID: 23775121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of hypoxia-inducible factor prolyl 4-hydroxylase 2 in FoxD1-lineage mesenchymal cells leads to congenital truncal alopecia.
    Rosendahl AH; Monnius M; Laitala A; Railo A; Miinalainen I; Heljasvaara R; Mäki JM; Myllyharju J
    J Biol Chem; 2022 Apr; 298(4):101787. PubMed ID: 35247391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIF-P4H-2 inhibition enhances intestinal fructose metabolism and induces thermogenesis protecting against NAFLD.
    Laitakari A; Tapio J; Mäkelä KA; Herzig KH; Dengler F; Gylling H; Walkinshaw G; Myllyharju J; Dimova EY; Serpi R; Koivunen P
    J Mol Med (Berl); 2020 May; 98(5):719-731. PubMed ID: 32296880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of HIF-P4H isoenzyme inhibition to metabolism indicates major beneficial effects being conveyed by HIF-P4H-2 antagonism.
    Tapio J; Halmetoja R; Dimova EY; Mäki JM; Laitala A; Walkinshaw G; Myllyharju J; Serpi R; Koivunen P
    J Biol Chem; 2022 Aug; 298(8):102222. PubMed ID: 35787374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic characteristics of transmembrane prolyl 4-hydroxylase (P4H-TM) deficient mice.
    Ala-Nisula T; Halmetoja R; Leinonen H; Kurkela M; Lipponen HR; Sakko S; Karpale M; Salo AM; Sissala N; Röning T; Raza GS; Mäkelä KA; Thevenot J; Herzig KH; Serpi R; Myllyharju J; Tanila H; Koivunen P; Dimova EY
    Pflugers Arch; 2024 Sep; 476(9):1339-1351. PubMed ID: 38396259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIF prolyl 4-hydroxylase-2 inhibition improves glucose and lipid metabolism and protects against obesity and metabolic dysfunction.
    Rahtu-Korpela L; Karsikas S; Hörkkö S; Blanco Sequeiros R; Lammentausta E; Mäkelä KA; Herzig KH; Walkinshaw G; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
    Diabetes; 2014 Oct; 63(10):3324-33. PubMed ID: 24789921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of transmembrane prolyl 4-hydroxylase reveals unique organization of EF and dioxygenase domains.
    Myllykoski M; Sutinen A; Koski MK; Kallio JP; Raasakka A; Myllyharju J; Wierenga RK; Koivunen P
    J Biol Chem; 2021; 296():100197. PubMed ID: 33334883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic long-term inactivation of hypoxia-inducible factor prolyl 4-hydroxylase 2 ameliorates aging-induced changes in mice without affecting their life span.
    Laitakari A; Huttunen R; Kuvaja P; Hannuksela P; Szabo Z; Heikkilä M; Kerkelä R; Myllyharju J; Dimova EY; Serpi R; Koivunen P
    FASEB J; 2020 Apr; 34(4):5590-5609. PubMed ID: 32100354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the hypoxia response pathway protects against age-induced cardiac hypertrophy.
    Röning T; Magga J; Laitakari A; Halmetoja R; Tapio J; Dimova EY; Szabo Z; Rahtu-Korpela L; Kemppi A; Walkinshaw G; Myllyharju J; Kerkelä R; Koivunen P; Serpi R
    J Mol Cell Cardiol; 2022 Mar; 164():148-155. PubMed ID: 34919895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency of a transmembrane prolyl 4-hydroxylase in the zebrafish leads to basement membrane defects and compromised kidney function.
    Hyvärinen J; Parikka M; Sormunen R; Rämet M; Tryggvason K; Kivirikko KI; Myllyharju J; Koivunen P
    J Biol Chem; 2010 Dec; 285(53):42023-32. PubMed ID: 20952382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.